Division of Neonatology, Careggi University Hospital of Florence, Florence, Italy.
Neonatal Intensive Care Unit, Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
Pediatr Pulmonol. 2022 May;57(5):1157-1166. doi: 10.1002/ppul.25875. Epub 2022 Mar 28.
Lung ultrasound (LU) has in recent years increasingly been used as a point-of-care method. Initially, LU was used as a so-called descriptive diagnostic method for neonatal respiratory diseases. Instead, this review article focuses on the use of LU as a "functional" tool using classification of findings in patterns or using semiquantitative scores. We review and describe the evidence that led to the implementation of LU in predicting the need for surfactant replacement therapy in preterm infants and in the identification of newborns at risk of developing bronchopulmonary dysplasia. LU appears to be a very promising method for the future of clinical management of newborns in both acute and chronic phases of pulmonary pathologies related to prematurity. However, further studies are needed to define its role before full implementation.
近年来,肺部超声(lung ultrasound,LU)越来越多地被用作一种即时护理方法。最初,LU 被用作一种所谓的描述性诊断方法,用于新生儿呼吸疾病。相反,本文重点介绍了 LU 作为一种“功能性”工具的使用,即通过分类发现模式或使用半定量评分。我们回顾并描述了导致 LU 在预测早产儿需要表面活性剂替代治疗以及识别有发生支气管肺发育不良风险的新生儿中的应用的证据。LU 似乎是一种非常有前途的方法,可用于未来对与早产相关的肺部疾病的急性和慢性阶段的新生儿进行临床管理。然而,在全面实施之前,还需要进一步的研究来确定其作用。